• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of iaiPermissionsJournals.ASM.orgJournalIAI ArticleJournal InfoAuthorsReviewers
Infect Immun. Jul 1989; 57(7): 2223–2229.
PMCID: PMC313864

Biological activities and chemical composition of purified tracheal cytotoxin of Bordetella pertussis.

Abstract

Specific destruction of ciliated epithelial cells lining the large airways is the primary respiratory tract cytopathology associated with human Bordetella pertussis infections. We have purified a single low-molecular-weight glycopeptide, tracheal cytotoxin (TCT), that appears to cause this pathology. By using a combination of solid-phase extraction and reversed-phase high-pressure liquid chromatography, about 700 nmol of biologically active peptide can be isolated from 1 liter of B. pertussis culture supernatant (approximately 60% yield). TCT at concentrations of 1 microM destroyed the ciliated cell population when incubated with respiratory epithelium in vitro. This concentration of TCT is similar to the concentrations found in the culture supernatant of growing B. pertussis. Purified TCT also inhibited DNA synthesis of hamster trachea epithelial cells in a quantitative, dose-dependent fashion. Endotoxin was not detected in the purified material, and neither B. pertussis nor Escherichia coli endotoxin could duplicate the biological activities of TCT. Amino acid and amino sugar analyses of purified TCT revealed the presence of glucosamine, muramic acid, alanine, glutamic acid, and diaminopimelic acid in molar ratios of 1:1:2:1:1. This suggests that TCT, the released ciliostatic principle of B. pertussis, is a disaccharide tetrapeptide subunit of peptidoglycan.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Adam A, Lederer E. Muramyl peptides: immunomodulators, sleep factors, and vitamins. Med Res Rev. 1984 Apr-Jun;4(2):111–152. [PubMed]
  • Bennett HP, Browne CA, Solomon S. Purification of the two major forms of rat pituitary corticotropin using only reversed-phase liquid chromatography. Biochemistry. 1981 Aug 4;20(16):4530–4538. [PubMed]
  • Bennett HP, Hudson AM, Kelly L, McMartin C, Purdon GE. A rapid method, using octadecasilyl-silica, for the extraction of certain peptides from tissues. Biochem J. 1978 Dec 1;175(3):1139–1141. [PMC free article] [PubMed]
  • Böhlen P, Castillo F, Ling N, Guillemin R. Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt. Int J Pept Protein Res. 1980 Oct;16(4):306–310. [PubMed]
  • Chedid L. Muramyl peptides as possible endogenous immunopharmacological mediators. Microbiol Immunol. 1983;27(9):723–732. [PubMed]
  • Collier AM, Peterson LP, Baseman JB. Pathogenesis of infection with Bordetella pertussis in hamster tracheal organ culture. J Infect Dis. 1977 Aug;136 (Suppl):S196–S203. [PubMed]
  • Dougherty TJ. Analysis of Neisseria gonorrhoeae peptidoglycan by reverse-phase, high-pressure liquid chromatography. J Bacteriol. 1985 Jul;163(1):69–74. [PMC free article] [PubMed]
  • Folkening WJ, Nogami W, Martin SA, Rosenthal RS. Structure of Bordetella pertussis peptidoglycan. J Bacteriol. 1987 Sep;169(9):4223–4227. [PMC free article] [PubMed]
  • Gentry-Weeks CR, Cookson BT, Goldman WE, Rimler RB, Porter SB, Curtiss R., 3rd Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium. Infect Immun. 1988 Jul;56(7):1698–1707. [PMC free article] [PubMed]
  • Goldman WE, Baseman JB. Selective isolation and culture of a proliferating epithelial cell population from the hamster trachea. In Vitro. 1980 Apr;16(4):313–319. [PubMed]
  • Goldman WE, Herwaldt LA. Bordetella pertussis tracheal cytotoxin. Dev Biol Stand. 1985;61:103–111. [PubMed]
  • Goldman WE, Klapper DG, Baseman JB. Detection, isolation, and analysis of a released Bordetella pertussis product toxic to cultured tracheal cells. Infect Immun. 1982 May;36(2):782–794. [PMC free article] [PubMed]
  • Hewlett E, Wolff J. Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization. J Bacteriol. 1976 Aug;127(2):890–898. [PMC free article] [PubMed]
  • Kotani S, Tsujimoto M, Koga T, Nagao S, Tanaka A, Kawata S. Chemical structure and biological activity relationship of bacterial cell walls and muramyl peptides. Fed Proc. 1986 Oct;45(11):2534–2540. [PubMed]
  • Lane BP, Gordon R. Regeneration of rat tracheal epithelium after mechanical injury. I. The relationship between mitotic activity and cellular differentiation. Proc Soc Exp Biol Med. 1974 Apr;145(4):1139–1144. [PubMed]
  • Martin SA, Rosenthal RS, Biemann K. Fast atom bombardment mass spectrometry and tandem mass spectrometry of biologically active peptidoglycan monomers from Neisseria gonorrhoeae. J Biol Chem. 1987 Jun 5;262(16):7514–7522. [PubMed]
  • Matrisian LM, Larsen BR, Finch JS, Magun BE. Further purification of epidermal growth factor by high-performance liquid chromatography. Anal Biochem. 1982 Sep 15;125(2):339–351. [PubMed]
  • Melly MA, McGee ZA, Rosenthal RS. Ability of monomeric peptidoglycan fragments from Neisseria gonorrhoeae to damage human fallopian-tube mucosa. J Infect Dis. 1984 Mar;149(3):378–386. [PubMed]
  • Muse KE, Collier AM, Baseman JB. Scanning electron microscopic study of hamster tracheal organ cultures infected with Bordetella pertussis. J Infect Dis. 1977 Dec;136(6):768–777. [PubMed]
  • Olson LC. Pertussis. Medicine (Baltimore) 1975 Nov;54(6):427–469. [PubMed]
  • Rosenthal RS. Release of soluble peptidoglycan from growing gonococci: hexaminidase and amidase activities. Infect Immun. 1979 Jun;24(3):869–878. [PMC free article] [PubMed]
  • Rosenthal RS, Nogami W, Cookson BT, Goldman WE, Folkening WJ. Major fragment of soluble peptidoglycan released from growing Bordetella pertussis is tracheal cytotoxin. Infect Immun. 1987 Sep;55(9):2117–2120. [PMC free article] [PubMed]
  • Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972 Dec;36(4):407–477. [PMC free article] [PubMed]
  • Sinha RK, Rosenthal RS. Release of soluble peptidoglycan from growing conococci: demonstration of anhydro-muramyl-containing fragments. Infect Immun. 1980 Sep;29(3):914–925. [PMC free article] [PubMed]
  • Smith AI, Keith AB, Edwardson JA, Biggins JA, McDermott JR. Characterization of corticotropin-like immunoreactive peptides in rat brain using high performance liquid chromatography. Neurosci Lett. 1982 May 28;30(2):133–138. [PubMed]
  • Smith CJ, Coote JG, Parton R. R-plasmid-mediated chromosome mobilization in Bordetella pertussis. J Gen Microbiol. 1986 Oct;132(10):2685–2692. [PubMed]
  • Stainer DW, Scholte MJ. A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol. 1970 Oct;63(2):211–220. [PubMed]
  • Weiss AA, Hewlett EL. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. [PubMed]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...